LMAT

LEMAITRE VASCULAR INC

LMAT·525558201·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

LMAT (LEMAITRE VASCULAR INC) is held by 149 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($314.1M), FIRST TRUST ADVISORS LP ($104.9M), CONGRESS ASSET MANAGEMENT CO ($92.5M). Net institutional sentiment: Mixed.

149
Holders
(11 Elite)
$1.6B
Total Value
56% (158)
Consensus
89 buying - 69 selling
13F: Insider & Congress: Updated regularly
LMAT

Smart Money Verdict

View all
Loading verdict
Held by 149 funds
11 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Sep 3, 2026 · Activists Jul 27, 2026 · Congress none

InsiderRARoush John AExercise 3K shSep 1, 2026
ActivistFTFirst Trust Portfolios L.P.5.2%Jul 27, 2026
InsiderLWLeMaitre George WVest 12K shJun 4, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
3.3M(+4.1%)$314.1M0.0%-8.68%
32
Increased
1.1M(+9.6%)$104.9M0.1%-2.44%
33
Increased
963,706(+15.5%)$92.5M0.6%+29.54%
48
Increased
953,437(+4.5%)$91.5M0.0%-23.24%
31
Increased
901,416(+5.3%)$86.5M0.0%+77.10%
31
Increased
788,835(+19.8%)$75.7M0.0%+34.62%
35
Increased
755,142(+156.0%)$72.5M0.0%-8.89%
48
Increased
604,833(+7.5%)$58M0.0%-23.00%
32
Increased
493,889(+3.7%)$47.4M0.0%+129.16%
30
Increased
473,194(+9.4%)$45.4M0.0%-1.26%
32
Increased
448,389(+34.3%)$43M0.0%-13.66%
38
Decreased
351,083(-13.9%)$33.7M0.0%+0.26%
0
Increased
333,325(+6.7%)$32M0.0%+94.06%
31
Increased
316,528(+12.3%)$30.4M0.0%-12.30%
32
Increased
308,765(+13.2%)$29.6M0.0%-2.31%
33
Increased
247,804(+498.3%)$23.8M0.0%-11.35%
46
Decreased
244,729(-10.8%)$23.5M0.0%+44.69%
0
Decreased
220,497(-4.4%)$21.2M0.1%-6.97%
0
Increased
206,764(+51.3%)$19.8M0.0%-0.32%
39
Increased
206,279(+4.2%)$19.8M0.0%+70.04%
30

Showing 1-20 of 169

1 / 9
LMATLMATLEMAITRE VASCULAR INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used